Provided by Tiger Fintech (Singapore) Pte. Ltd.

Timber Pharmaceuticals

0.3426
0.0000
Volume:- -
Turnover:108.12K
Market Cap:1.06M
PE:-0.07
High:0.3426
Open:0.3426
Low:0.3426
Close:0.3426
Loading ...

Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market

StreetInsider
·
30 Nov 2023

BRIEF-Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business

Reuters
·
29 Nov 2023

Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American

GlobeNewswire
·
28 Nov 2023

Timber Pharmaceuticals Shares Fall 69% After Chapter 11 Filing, Delisting Notice

Dow Jones
·
22 Nov 2023

BRIEF-NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals

Reuters
·
21 Nov 2023

NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals, Inc. (TMBR)

StreetInsider
·
21 Nov 2023

Timber Pharmaceuticals Files for Chapter 11, Signs Asset-Sale Pact With LEO Pharma

Dow Jones
·
18 Nov 2023

BRIEF-Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A "Stalking Horse" Asset Purchase Agreement

Reuters
·
18 Nov 2023

BRIEF-Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy - Court Filing

Reuters
·
18 Nov 2023

Timber Pharmaceuticals Stockholders Don't Approve Sale to LEO Pharma

marketwatch
·
18 Nov 2023

BRIEF-Timber Pharmaceuticals Says Proposal To Approve Merger Agreement Was Not Approved In Special Meeting

Reuters
·
18 Nov 2023

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance

StreetInsider
·
22 Sep 2023

BRIEF-Timber Pharmaceuticals Announces NYSE Acceptance Of Plan To Regain Listing Compliance

Reuters
·
19 Sep 2023

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance

GlobeNewswire
·
18 Sep 2023